BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 25251885)

  • 1. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.
    Strang J; Metrebian N; Lintzeris N; Potts L; Carnwath T; Mayet S; Williams H; Zador D; Evers R; Groshkova T; Charles V; Martin A; Forzisi L
    Lancet; 2010 May; 375(9729):1885-95. PubMed ID: 20511018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.
    Groshkova T; Metrebian N; Hallam C; Charles V; Martin A; Forzisi L; Lintzeris N; Strang J
    Drug Alcohol Rev; 2013 Nov; 32(6):566-73. PubMed ID: 24118500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.
    Lintzeris N; Strang J; Metrebian N; Byford S; Hallam C; Lee S; Zador D;
    Harm Reduct J; 2006 Sep; 3():28. PubMed ID: 17002810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.
    Strang J; Marsden J; Cummins M; Farrell M; Finch E; Gossop M; Stewart D; Welch S
    Addiction; 2000 Nov; 95(11):1631-45. PubMed ID: 11219367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions.
    Metrebian N; Shanahan W; Wells B; Stimson GV
    Med J Aust; 1998 Jun; 168(12):596-600. PubMed ID: 9673620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised Injectable Heroin: A Clinical Perspective.
    Bell J; Waal RV; Strang J
    Can J Psychiatry; 2017 Jul; 62(7):451-456. PubMed ID: 28683227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting biopsychosocial outcomes for heroin users in primary care treatment: a prospective longitudinal cohort study.
    Parmenter J; Mitchell C; Keen J; Oliver P; Rowse G; Neligan I; Keil C; Mathers N
    Br J Gen Pract; 2013 Jul; 63(612):e499-505. PubMed ID: 23834887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†.
    Strang J; Groshkova T; Uchtenhagen A; van den Brink W; Haasen C; Schechter MT; Lintzeris N; Bell J; Pirona A; Oviedo-Joekes E; Simon R; Metrebian N
    Br J Psychiatry; 2015 Jul; 207(1):5-14. PubMed ID: 26135571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.
    Oviedo-Joekes E; Marchand K; Guh D; Marsh DC; Brissette S; Krausz M; Anis A; Schechter MT
    Addict Behav; 2011; 36(1-2):55-60. PubMed ID: 20855171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supervised Injectable Opioid Treatment for the Management of Opioid Dependence.
    Bell J; Belackova V; Lintzeris N
    Drugs; 2018 Sep; 78(13):1339-1352. PubMed ID: 30132259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an 18-month, NHS-based, treatment exposure for heroin dependence: results from the London Area Treat 2000 Study.
    Schifano F; Martinotti G; Cunniff A; Reissner V; Scherbaum N; Ghodse H
    Am J Addict; 2012; 21(3):268-73. PubMed ID: 22494230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.
    Blanken P; Hendriks VM; van Ree JM; van den Brink W
    Addiction; 2010 Feb; 105(2):300-8. PubMed ID: 19922517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
    Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
    Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.